Publications by authors named "Daniel S Tan"

Claim this Profile
S
Sevabertinib in Advanced -Mutant Non-Small-Cell Lung Cancer.
Xiuning Le, Tae Min Kim, Herbert H Loong, Arsela Prelaj, Boon Cher Goh, Daniel Shao-Weng Tan

N Engl J Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zipalertinib in Patients With Epidermal Growth Factor Receptor Exon 20 Insertion-Positive Non-Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy With or Without Amivantamab.
Zofia Piotrowska, Antonio Passaro, Danny Nguyen, Gerrina Ruiter, Ross A Soo, Daniel Shao-Weng Tan

J Clin Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
REZILIENT3: randomized phase III study of first-line zipalertinib plus chemotherapy in patients with exon 20 insertion-mutated NSCLC.
John V Heymach, Helena A Yu, Benjamin Besse, Ying Cheng, Daniel Sw Tan

Future Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capmatinib plus nazartinib in patients with EGFR-mutated non-small cell lung cancer.
Enriqueta Felip, Giulio Metro, Ross A Soo, Jürgen Wolf, Benjamin J Solomon, Daniel Sw Tan

Eur J Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncogene-Driven Non-Small Cell Lung Cancers in Patients with a History of Smoking Lack Smoking-Induced Mutations.
Chen-Yang Huang, Nanhai Jiang, Meixin Shen, Gillianne G Lai, Aaron C Tan, Eng Huat Tan, Wan Ling Tan, Daniel S Tan

Cancer Res· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards proactive palliative care in oncology: developing an explainable EHR-based machine learning model for mortality risk prediction.
Qingyuan Zhuang, Alwin Yaoxian Zhang, Ryan Shea Tan Ying Cong, Grace Meijuan Yang, Patricia Soek Hui Neo, Daniel Sw Tan, Iain Beehuat Tan

BMC Palliat Care· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR-mutated lung cancer treated with the first-/second-generation tyrosine kinase inhibitors.
Michael Menzel, Martina Kirchner, Klaus Kluck, Markus Ball, Susanne Beck, Daniel Sw Tan

J Pathol Clin Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pralsetinib in patients with RET fusion-positive non-small-cell lung cancer: A plain language summary of the ARROW study.
Frank Griesinger, Giuseppe Curigliano, Vivek Subbiah, Christina S Baik, Daniel Sw Tan

Future Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies.
Chia-Chi Lin, Elena Garralda, Patrick Schöffski, David S Hong, Lillian L Siu, Daniel Sw Tan, Tanay S Samant

Oncoimmunology· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combinatorial Hypofractionated Radiotherapy and Pembrolizumab in Anaplastic Thyroid Cancer.
Janice Ser Huey Tan, Timothy Kwang Yong Tay, Enya Hui Wen Ong, Michael Fehlings, Daniel Shao-Weng Tan

Eur Thyroid J· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic Evaluations of Imaging Biomarker-Driven Companion Diagnostics for Cancer: A Systematic Review.
Sibo Liu, Daniel Sw Tan, Nicholas Graves, Ann-Marie Chacko

Appl Health Econ Health Policy· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Tolerability, and Antitumor Activity of Zipalertinib Among Patients With Non-Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 20 Insertions.
Zofia Piotrowska, Daniel Shao-Weng Tan, Egbert F Smit, Alexander I Spira, Ross A Soo

J Clin Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical efficacy and biomarker analysis of dual PD-1/CTLA-4 blockade in recurrent/metastatic EBV-associated nasopharyngeal carcinoma.
Darren Wan-Teck Lim, Hsiang-Fong Kao, Lisda Suteja, Constance H Li, Hong Sheng Quah, Daniel Shao-Weng Tan, Sze-Huey Tan, Eng-Huat Tan, Wan-Ling Tan

Nat Commun· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real world efficacy of osimertinib in second line/beyond in patients with metastatic EGFR+ non-small cell lung cancer and role of paired tumour-plasma T790M testing at tyrosine kinase inhibitor resistance.
Jun Ma, Sze Huey Tan, Daniel Xing Cheng Yin, Nguyen Tuan Anh Tran, Gek San Tan, Tanujaa Rajasekaran, Eng-Huat Tan, Daniel Shao-Weng Tan, Wan Ling Tan

Transl Lung Cancer Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asian Thoracic Oncology Research Group (ATORG) Expert Consensus Statement on MET Alterations in NSCLC: Diagnostic and Therapeutic Considerations.
Myung-Ju Ahn, Marvin Jonne L Mendoza, Nick Pavlakis, Terufumi Kato, Ross A Soo, Thanyanan Reungwetwattana, Daniel Shao-Weng Tan

Clin Lung Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Immunotherapy in Patients with Early-Stage Non-small Cell Lung Cancer and Future Directions.
Stephanie Pl Saw, Mei-Kim Ang, Daniel Sw Tan

Curr Treat Options Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exquisitely Platinum-Sensitive Triple-Negative Breast Cancer, Time for Methylation Testing?
Tira J Tan, J Lynn Fink, Timothy K Tay, Binny Jaradi, Nathan Stone, Puay Hoon Tan, Daniel S Tan

JCO Precis Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world global data on targeting epidermal growth factor receptor mutations in stage III non-small-cell lung cancer: the results of the KINDLE study.
Abdul Rahman Jazieh, Huseyin Cem Onal, Daniel Shao-Weng Tan, Ross A Soo, Kumar Prabhash

Ther Adv Med Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer.
Shigeki Nanjo, Wei Wu, Niki Karachaliou, Collin M Blakely, Junji Suzuki, Aaron C Tan, Daniel Sw Tan

J Clin Invest· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controllable and Identity-Aware Facial Attribute Transformation.
Daniel Stanley Tan, Jonathan Hans Soeseno, Kai-Lung Hua

IEEE Trans Cybern· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing the effect of a consult model versus an integrated palliative care and medical oncology co-rounding model on health care utilization in an acute hospital - an open-label stepped-wedge cluster-randomized trial.
Grace M Yang, Siqin Zhou, Zhizhen Xu, Stella Sl Goh, Xia Zhu, Daniel Sw Tan

Palliat Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming the impact of the COVID-19 pandemic on oncology early phase trials and drug development in Asia-Experiences and perspectives of the Asian Oncology Early Phase 1 Consortium.
Toshio Shimizu, Dong-Wan Kim, Herbert H Loong, Chia-Chi Lin, Matthew Ch Ng, Daniel Sw Tan

Asia Pac J Clin Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complementary Sequential Circulating Tumor Cell (CTC) and Cell-Free Tumor DNA (ctDNA) Profiling Reveals Metastatic Heterogeneity and Genomic Changes in Lung Cancer and Breast Cancer.
Say Li Kong, Xingliang Liu, Swee Jin Tan, Joyce A Tai, Ler Yee Phua, Tira J Tan, Daniel Shao-Weng Tan

Front Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of nimotuzumab (TheraCim-hR3) concurrent with cisplatin/radiotherapy in patients with locally advanced head and neck squamous cell carcinoma.
Mei-Kim Ang, Jose Enrique Montoya, Ekkasit Tharavichitkul, Cindy Lim, Terence Tan, Daniel Shao-Weng Tan, Eng-Huat Tan

Head Neck· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experimental and bioinformatics considerations in cancer application of single cell genomics.
Joanna Hui Juan Tan, Say Li Kong, Joyce A Tai, Huay Mei Poh, Fei Yao, Daniel Shao-Weng Tan

Comput Struct Biotechnol J· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis